Correlation Between Sam-A Pharm and Kolon Life

Can any of the company-specific risk be diversified away by investing in both Sam-A Pharm and Kolon Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sam-A Pharm and Kolon Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sam A Pharm Co and Kolon Life Science, you can compare the effects of market volatilities on Sam-A Pharm and Kolon Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sam-A Pharm with a short position of Kolon Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sam-A Pharm and Kolon Life.

Diversification Opportunities for Sam-A Pharm and Kolon Life

0.26

Correlation Coefficient

Sam-A Pharm  Kolon Life

Modest diversification

The 3 months correlation between Sam-A and Kolon is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Sam A Pharm Co and Kolon Life Science in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kolon Life Science and Sam-A Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sam A Pharm Co are associated (or correlated) with Kolon Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kolon Life Science has no effect on the direction of Sam-A Pharm i.e., Sam-A Pharm and Kolon Life go up and down completely randomly.

Pair Corralation between Sam-A Pharm and Kolon Life

Assuming the 90 days trading horizon Sam A Pharm Co is expected to under-perform the Kolon Life. But the stock apears to be less risky and, when comparing its historical volatility, Sam A Pharm Co is 1.12 times less risky than Kolon Life. The stock trades about -0.18 of its potential returns per unit of risk. The Kolon Life Science is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1,878,000  in Kolon Life Science on September 13, 2024 and sell it today you would earn a total of  157,000  from holding Kolon Life Science or generate 8.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sam A Pharm Co  vs.  Kolon Life Science

Sam A Pharm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sam A Pharm Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Kolon Life Science

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Kolon Life Science are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kolon Life may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Sam-A Pharm and Kolon Life

The main advantage of trading using opposite Sam-A Pharm and Kolon Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sam-A Pharm position performs unexpectedly, Kolon Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kolon Life will offset losses from the drop in Kolon Life's long position.

The idea behind Sam A Pharm Co and Kolon Life Science pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.